The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma

Shikha Bose, Lee Fah Yap, Matthew Fung, Jane Starzcynski, Amyza Saleh, Susan Morgan, Christopher Dawson, Marilyn B. Chukwuma, Esther Maina, Maike Buettner, Wenbin Wei, John Arrand, Paul V.H. Lim, Lawrence S. Young, Soo Hwang Teo, Tatjana Stankovic, Ciaran B.J. Woodman, Paul G. Murray

Research output: Contribution to journalArticlepeer-review

Abstract

A micro-array analysis using biopsies from patients with EBV-positive undifferentiated nasopharyngeal carcinoma (NPC) and from cancer-free controls revealed down-regulation of tumour suppressor genes (TSG) not previously associated with this disease; one such gene was the ataxia telangiectasia mutated (ATM) gene. Q-PCR confirmed down-regulation of ATM mRNA and ATM protein expression in tumour cells was weak or absent in almost all cases. In NPC cell lines, however, ATM was down-regulated only in the EBV-positive line, C666.1, and in none of five EBV-negative lines. In vitro infection of EBV-negative NPC cell lines with a recombinant EBV was followed by the down-regulation of ATM mRNA and protein, and only EBV-positive cells showed a defective DNA damage response following γ-irradiation. Our data suggest that loss of ATM function could be an important step in the pathogenesis of NPC, and may have implications for the treatment of this disease.

Original languageEnglish
Pages (from-to)345-352
Number of pages8
JournalThe Journal of Pathology
Volume217
Issue number3
DOIs
Publication statusPublished - Feb 2009
Externally publishedYes

Keywords

  • ATM
  • Epstein-Barr virus
  • Nasopharyngeal carcinoma

Fingerprint

Dive into the research topics of 'The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma'. Together they form a unique fingerprint.

Cite this